Home/ Stocks/ PLUR

Pluri Inc. Common Stock

PLUR XNAS

$1.24 -0.12 (-10.08%) ▼ 15-min delayed

Open

$1.19

High

$1.24

Low

$1.18

Volume

4.8K

Market Cap

$16.70M

About Pluri Inc. Common Stock

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 113 Website →

Related Market News

No specific coverage for PLUR yet. Check out our latest market news or earnings calendar.

Get PLUR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Pluri Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.